Considering that complement activation itself can contribute to vasculitis or thrombotic conditions, TSP-1 may also be involved in mitigating the sequelae of an overactive complement system, further preventing anaphylatoxin C3a and C5a formation (18, 19, 47). Here, C3 is linked to vasculitis.